Benzinga · Aug 10, 2026
Canaccord Genuity Maintains Buy on Orthofix Medical, Lowers Price Target to $13
Canaccord Genuity analyst Caitlin Burrows maintains Orthofix Medical (NASDAQ:OFIX) with a Buy and lowers the price target from $18 to $13.
OF
NASDAQ · OFIX
Orthofix Medical Inc.
Healthcare · Medical - Devices
$9.09
Down-$0.12 (-1.30%)
Updated Oct 3, 2026, 2:02 AM
SID Score
3.5/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 622.51M
- P/E ratio
- -5.25
- Dividend yield
- 0.00%
- 52-week range
- $8.50 – $16.99
- Volume
- 319.19K
- Avg. volume
- 261.03K
Price performance · OFIX
OFIX price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 2, 2026
OFIX closed at $9.09 after 20 trading sessions, down 2.15% for the selected period.
- Last close
- $9.09
- Period change
- -2.15%
- Period low
- $8.64
- Period high
- $9.84
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 2, 2026 | $9.26 | $9.33 | $9.07 | $9.09 | 319.19K |
| Oct 1, 2026 | $9.44 | $9.57 | $9.16 | $9.21 | 525.35K |
| Sep 30, 2026 | $9.75 | $9.75 | $9.38 | $9.41 | 588.03K |
| Sep 29, 2026 | $9.80 | $9.82 | $9.49 | $9.75 | 433.76K |
| Sep 28, 2026 | $9.33 | $9.865 | $9.19 | $9.84 | 438.1K |
| Sep 25, 2026 | $9.21 | $9.94 | $9.115 | $9.44 | 743.73K |
| Sep 24, 2026 | $9.23 | $9.35 | $8.99 | $9.16 | 439K |
| Sep 23, 2026 | $9.02 | $9.27 | $8.88 | $9.18 | 437.7K |
| Sep 22, 2026 | $9.04 | $9.21 | $8.945 | $8.98 | 256.92K |
| Sep 21, 2026 | $8.72 | $8.98 | $8.57 | $8.95 | 574.26K |
| Sep 18, 2026 | $8.54 | $8.81 | $8.50 | $8.71 | 610.25K |
| Sep 17, 2026 | $8.94 | $9.06 | $8.615 | $8.64 | 193.81K |
| Sep 16, 2026 | $9.09 | $9.11 | $8.79 | $8.90 | 230.29K |
| Sep 15, 2026 | $9.09 | $9.14 | $8.87 | $9.09 | 263.35K |
| Sep 14, 2026 | $8.99 | $9.20 | $8.91 | $9.11 | 324.72K |
| Sep 11, 2026 | $8.80 | $8.985 | $8.615 | $8.93 | 436.09K |
| Sep 10, 2026 | $8.90 | $8.93 | $8.67 | $8.69 | 313.15K |
| Sep 9, 2026 | $9.13 | $9.2097 | $8.83 | $8.91 | 565.53K |
| Sep 8, 2026 | $9.17 | $9.26 | $8.97 | $9.15 | 322.64K |
| Sep 4, 2026 | $9.22 | $9.36 | $9.15 | $9.29 | 202.59K |
Latest OFIX news
The latest Smart Investors Daily articles mentioning OFIX.
Stock researchCompany · Overview
Company
Market Activity
Research & News
OFIX research
Overview
Company profile and research snapshot.
Company profile
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two main segments: global spine, including bone growth and healing therapies, spinal implants, and regenerative tissue products; and global orthopedics, providing products used in fracture repair, deformity correction, and bone reconstruction procedures. The majority of the company's sales come from the global spine segment in the United States. Orthofix distributes its products throughout North America, Europe, and several countries across the globe. The company provides solutions to hospitals, physicians, other healthcare providers, and patients.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $20.00
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 10, 2026 | Canaccord Genuity | Buy | — |
| Jul 6, 2026 | Barrington Research | Outperform | — |
| May 22, 2026 | Canaccord Genuity | Buy | — |
| May 22, 2026 | Barrington Research | Outperform | — |
| May 22, 2026 | Stifel | Buy | — |
News briefing
No generated briefing is available yet.
ChartMill · Aug 5, 2026
Orthofix Medical (NASDAQ:OFIX) Jumps on Q2 Earnings Beat and Raised Guidance
Orthofix Medical (OFIX) beats Q2 profit estimates, raises full-year 2026 guidance; stock up ~9.6% premarket despite in-line revenue.
SeekingAlpha · Aug 5, 2026
Orthofix Medical Inc. (OFIX) Q2 2026 Earnings Call Transcript
Orthofix Medical Inc. (OFIX) Q2 2026 Earnings Call August 5, 2026 8:30 AM EDTCompany ParticipantsJulie Dewey - Chief Investor Relations & Communications...
SeekingAlpha · Aug 5, 2026
Orthofix Medical Inc. 2026 Q2 - Results - Earnings Call Presentation
2026-08-05. The following slide deck was published by Orthofix Medical Inc.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
